Cargando…

Atypical HUS caused by anti-complement factor H antibody: a hematologist's perspective

Detalles Bibliográficos
Autores principales:	Kumar, Meet, Mandal, Prakas, De, Rajib, Mukherjee, Pinaki, Dolai, Tuphan Kanti, Bhattyacharyya, Maitryee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377346/ https://www.ncbi.nlm.nih.gov/pubmed/25830136 http://dx.doi.org/10.5045/br.2015.50.1.63

Ejemplares similares

Imatinib causing drug rash with eosinophilia and systemic symptoms: A rare cutaneous reaction
por: Kumar, Meet, et al.
Publicado: (2014)

A rare case of isolated myeloid sarcoma of the small gut with inv(16)(p13;q22) without bone marrow involvement
por: Mandal, Prakas Kumar, et al.
Publicado: (2014)

Primary systemic amyloidosis with sole cutaneous involvement
por: Mandal, Prakas Kumar, et al.
Publicado: (2014)

Trephine biopsy in an elderly man revealed double pathology
por: Mandal, Prakas Kumar, et al.
Publicado: (2015)

Primary bone lymphoma with multifocal osteolytic lesions: a rare case report with review of literature
por: Mandal, Prakas Kumar, et al.
Publicado: (2015)

Genetics and complement in atypical HUS
por: Kavanagh, David, et al.
Publicado: (2010)

Outbreak of Burkholderia Cepacia Infection: a Systematic Study in a Hematolooncology Unit of a Tertiary Care Hospital from Eastern India
por: Baul, Shuvra Neel, et al.
Publicado: (2018)

Lenalidomide-Induced Pure Red Cell Aplasia
por: Dolai, Tuphan Kanti, et al.
Publicado: (2014)

Utility of (18)F-fluorodeoxyglucose PET-CT scan in detecting bone marrow involvement in lymphoma
por: Jitani, Ankit Kumar, et al.
Publicado: (2021)

Complement therapy in atypical haemolytic uraemic syndrome (aHUS)
por: Wong, Edwin K.S., et al.
Publicado: (2013)

COVID-19 as a potential trigger of complement-mediated atypical HUS
por: El Sissy, Carine, et al.
Publicado: (2021)

Pattern of autologous stem cell transplants at a tertiary care government hospital, with emphasis on transplant outcomes with pre-harvest CD34+ level
por: Dolai, Tuphan Kanti, et al.
Publicado: (2022)

aHUS caused by complement dysregulation: new therapies on the horizon
por: Waters, Aoife M., et al.
Publicado: (2010)

Atypical HUS and Crohn’s disease—interference of intestinal disease activity with complement-blocking treatment
por: Horváth, Orsolya, et al.
Publicado: (2021)

Erratum to: aHUS caused by complement dysregulation: new therapies on the horizon
por: Waters, Aoife M., et al.
Publicado: (2012)

Risk of Atypical HUS Among Family Members of Patients Carrying Complement Regulatory Gene Abnormality
por: Ardissino, Gianluigi, et al.
Publicado: (2021)

Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura
por: Oh, Jisu, et al.
Publicado: (2019)

Shoulder pain: a hematologist’s perspective
por: Jain, Ankur, et al.
Publicado: (2016)

Atypical HUS relapse triggered by COVID-19
por: Ville, Simon, et al.
Publicado: (2021)

Atypical HUS with multiple complement system mutations triggered by synthetic psychoactive drug abuse: a case report
por: Jelicic, Ivo, et al.
Publicado: (2023)

Acute Mesenteric Thrombosis: A Hematologist Perspective
por: Moiz, Bushra, et al.
Publicado: (2020)

Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
por: Fakhouri, Fadi, et al.
Publicado: (2021)

Gaucher Disease for Hematologists
por: Özdemir, Gül Nihal, et al.
Publicado: (2022)

Atypical HUS Associated with CFH/CFHR-1 Hybrid Gene
por: Negi, Sharon, et al.
Publicado: (2020)

Atypical HUS Triggered by COVID-19: A Case Report
por: Tiwari, Vaibhav, et al.
Publicado: (2022)

Case Report: Neonatal Unexplained HUS Treated With Complement Inhibitor Eculizumab
por: Kelen, Dorottya, et al.
Publicado: (2021)

Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist’s perspective
por: Kritharis, Athena, et al.
Publicado: (2018)

Use of Eculizumab During Pregnancy in Kidney Transplant Recipients With Atypical HUS
por: Cheung, Chee Kay, et al.
Publicado: (2019)

Pulmonary Renal Syndrome due to Atypical HUS in a Young Gentleman
por: Rajarajan, Arun P., et al.
Publicado: (2023)

PB2351: ANXIETY AT THE HEMATOLOGIST
por: Trojan, S., et al.
Publicado: (2022)

Immunosuppressive Therapy of Antibody-Mediated aHUS and TTP
por: Kelen, Kata, et al.
Publicado: (2023)

A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
por: Rathbone, John, et al.
Publicado: (2013)

Atypical Hemolytic Uremic Syndrome: Differential Diagnosis from TTP/HUS and Management
por: Yenerel, Mustafa N.
Publicado: (2014)

Clinical Relapses of Atypical HUS on Eculizumab: Clinical Gap for Monitoring and Individualised Therapy
por: Teoh, Chia Wei, et al.
Publicado: (2018)

The Central Role of Fibrinolytic Response in COVID-19—A Hematologist’s Perspective
por: Kwaan, Hau C., et al.
Publicado: (2021)

Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS
por: Valoti, Elisabetta, et al.
Publicado: (2019)

Typical Hus: Evidence of Acute Phase Complement Activation from a Daycare Outbreak
por: Brady, Tammy M, et al.
Publicado: (2016)

Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies
por: Borah, Pronamee, et al.
Publicado: (2021)

SARS-CoV-2 Infected Patient: from a Hematologist’s Perspective
por: Kreidieh, Firas, et al.
Publicado: (2020)

Acquired von Willebrand syndrome: focused for hematologists
por: Franchini, Massimo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pkgnssjpso10lll3a6jd24bje6